Rhumbline Advisers lifted its stake in shares of Exponent, Inc. (NASDAQ:EXPO - Free Report) by 3.1% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 184,891 shares of the business services provider's stock after buying an additional 5,606 shares during the quarter. Rhumbline Advisers owned about 0.36% of Exponent worth $14,987,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds also recently modified their holdings of EXPO. Raymond James Financial Inc. bought a new stake in Exponent during the 4th quarter valued at $55,131,000. Norges Bank acquired a new position in shares of Exponent during the fourth quarter valued at about $52,381,000. Resona Asset Management Co. Ltd. bought a new stake in shares of Exponent during the fourth quarter worth about $38,538,000. BLI Banque de Luxembourg Investments bought a new stake in shares of Exponent during the fourth quarter worth about $12,564,000. Finally, Barclays PLC raised its holdings in shares of Exponent by 88.5% in the 4th quarter. Barclays PLC now owns 181,921 shares of the business services provider's stock worth $16,209,000 after acquiring an additional 85,395 shares during the last quarter. Institutional investors own 92.37% of the company's stock.
Exponent Trading Down 0.8%
NASDAQ EXPO traded down $0.59 during trading hours on Thursday, hitting $75.63. The company's stock had a trading volume of 314,918 shares, compared to its average volume of 251,024. The company's 50-day simple moving average is $77.96 and its two-hundred day simple moving average is $85.16. The company has a market capitalization of $3.84 billion, a PE ratio of 35.67 and a beta of 0.92. Exponent, Inc. has a 52 week low of $73.37 and a 52 week high of $115.75.
Exponent (NASDAQ:EXPO - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The business services provider reported $0.52 EPS for the quarter, beating the consensus estimate of $0.48 by $0.04. Exponent had a net margin of 19.52% and a return on equity of 27.27%. The firm had revenue of $137.44 million during the quarter, compared to analyst estimates of $134.63 million. During the same quarter last year, the business posted $0.59 EPS. The company's revenue for the quarter was up .2% on a year-over-year basis. Research analysts anticipate that Exponent, Inc. will post 1.98 EPS for the current fiscal year.
Exponent Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, June 20th. Investors of record on Friday, June 6th will be issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.59%. The ex-dividend date is Friday, June 6th. Exponent's dividend payout ratio (DPR) is presently 58.54%.
Insiders Place Their Bets
In other Exponent news, VP Bradley A. James sold 2,694 shares of the firm's stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $79.52, for a total transaction of $214,226.88. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, VP Joseph Rakow sold 1,573 shares of Exponent stock in a transaction dated Tuesday, May 27th. The stock was sold at an average price of $77.72, for a total value of $122,253.56. The disclosure for this sale can be found here. Insiders have sold 6,267 shares of company stock worth $489,120 in the last three months. 2.10% of the stock is currently owned by corporate insiders.
About Exponent
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Further Reading

Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.